GB:0N4A Stock Latest News
Company AnnouncementsVivesto boosts Paccal Vet’s global profile with new oncology data at WSAVA 20262w ago
Company AnnouncementsVivesto’s Paccal Vet Data Spotlighted at Key Veterinary Oncology Conference1M ago
Company AnnouncementsVivesto’s Paccal Vet Shows Promising Efficacy and Safety in Feline Cancer Study1M ago
Company AnnouncementsVivesto’s Paccal Vet Shows Survival Benefit in Canine Hemangiosarcoma Study1M ago
Company AnnouncementsVivesto Sets Maximum Tolerated Dose in Feline Paccal Vet Cancer Study4M ago
Company AnnouncementsVivesto completes dog cancer trial recruitment as Paccal Vet nears key data readout4M agoCompany AnnouncementsVivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data4M ago
Company AnnouncementsVivesto’s Cantrixil Clears Key Preclinical Hurdle With Positive i.v. Safety Data4M ago
Company AnnouncementsVivesto names seasoned life science financier Björn Svanström as new CFO5M ago- Company AnnouncementsVivesto Cuts Share Count After 1-for-100 Reverse Split5M ago
Company AnnouncementsVivesto Sets Timetable for 1:100 Reverse Share Split5M ago
Company AnnouncementsVivesto AGM Backs Reverse Share Split and Capital Cut to Streamline Structure5M ago
Company AnnouncementsVivesto Plans Major Reverse Share Split and Share Capital Reduction7M ago
- Company AnnouncementsVivesto Boosts Share Count After Rights and Set-Off Issues8M ago
- Company AnnouncementsVivesto Settles Rights Issue Guarantee Fees with Directed Share Issue to Preserve Cash9M ago
- Company AnnouncementsVivesto Raises SEK 53.8 Million in Fully Subscribed Rights Issue With Significant Shareholder Dilution9M ago
Company AnnouncementsVivesto Launches Fully Covered SEK 53.8 Million Rights Issue to Fund Veterinary Oncology Pipeline10M ago
Company AnnouncementsVivesto Shareholders Approve Heavily Guaranteed Rights Issue to Bolster Cancer Drug Development10M agoCompany AnnouncementsVivesto Engages Liberi Group to Boost Partnering for Key Oncology Programs10M ago